Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial

[1] Burns JC(2004)Kawasaki syndrome Lancet. 364 533-544

[2] Glode MP(2019)Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016 Pediatr Int. 61 397-403

[3] Makino N(2019)Epidemiologic features of Kawasaki ddisease in Shanghai from 2013 through 2017 J Epidemiol. 30 429-435

[4] Nakamura Y(2009)When children with Kawasaki disease grow up: myocardial and vascular complications in adulthood J Am Coll Cardiol. 54 1911-1920

[5] Yashiro M(2004)Meta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease Mod Rheumatol. 14 361-366

[6] Kosami K(1997)Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose J Pediatr. 131 888-893

[7] Matsubara Y(2005)Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children Pediatrics. 116 989-995

[8] Ae R(2007)Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease N Engl J Med. 356 663-675

[9] Aoyama Y(2012)Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial Lancet. 379 1613-1620

[10] Yanagawa H(2012)A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease Eur J Pediatr. 171 571-578

[1] Burns JC(2004)Kawasaki syndrome Lancet. 364 533-544

[2] Glode MP(2019)Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016 Pediatr Int. 61 397-403

[3] Makino N(2019)Epidemiologic features of Kawasaki ddisease in Shanghai from 2013 through 2017 J Epidemiol. 30 429-435

[4] Nakamura Y(2009)When children with Kawasaki disease grow up: myocardial and vascular complications in adulthood J Am Coll Cardiol. 54 1911-1920

[5] Yashiro M(2004)Meta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease Mod Rheumatol. 14 361-366

[6] Kosami K(1997)Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose J Pediatr. 131 888-893

[7] Matsubara Y(2005)Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children Pediatrics. 116 989-995

[8] Ae R(2007)Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease N Engl J Med. 356 663-675

[9] Aoyama Y(2012)Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial Lancet. 379 1613-1620

[10] Yanagawa H(2012)A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease Eur J Pediatr. 171 571-578